Institutional investors hold a majority ownership of FOLD through the 107.54% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2017, these large investors purchased a net $6.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MEDICAL STRATEGY GMBH Bought 61.0 Thousand shares of Amicus Therapeutics Inc
NOVACAP ASSET MANAGEMENT SA Bought 7.3 Thousand shares of Amicus Therapeutics Inc